Niacin-and-statin trial ends early; no benefit to raising HDL
|
|
( iStock photo ) The NIH announced May 26 it has stopped a trial 18 months ahead of schedule after finding that combining extended-release, high-dose niacin with a statin doesn't seem to reduce the risk of adverse cardiovascular events like heart attacks and strokes. |
E-mail
Twitter
Facebook
StumbleUpon
Comments are filtered for language and registration is required. The Times makes no guarantee of comments' factual accuracy. Readers may report inappropriate comments by clicking the Report Abuse link next to a comment. Here are the full legal terms you agree to by using this comment form.
Currently there are no comments. Be the first to comment!